Clinica Baviera Valuation
| CBAV Stock | EUR 35.10 0.50 1.45% |
At this time, the firm appears to be undervalued. Clinica Baviera shows a prevailing Real Value of €39.88 per share. The current price of the firm is €35.1. Our model approximates the value of Clinica Baviera from analyzing the firm fundamentals such as Profit Margin of 0.15 %, return on equity of 0.47, and Current Valuation of 301.63 M as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Clinica Baviera's price fluctuation is very steady at this time. Calculation of the real value of Clinica Baviera is based on 3 months time horizon. Increasing Clinica Baviera's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Clinica Baviera is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Clinica Stock. However, Clinica Baviera's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 35.1 | Real 39.88 | Hype 34.6 | Naive 35.63 |
The real value of Clinica Stock, also known as its intrinsic value, is the underlying worth of Clinica Baviera Company, which is reflected in its stock price. It is based on Clinica Baviera's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Clinica Baviera's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Clinica Baviera helps investors to forecast how Clinica stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Clinica Baviera more accurately as focusing exclusively on Clinica Baviera's fundamentals will not take into account other important factors: Clinica Baviera Total Value Analysis
Clinica Baviera is currently forecasted to have takeover price of 301.63 M with market capitalization of 308.14 M, debt of 6.52 M, and cash on hands of 10.79 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Clinica Baviera fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
301.63 M | 308.14 M | 6.52 M | 10.79 M |
Clinica Baviera Investor Information
About 92.0% of the company shares are held by company insiders. The book value of Clinica Baviera was currently reported as 4.27. The company last dividend was issued on the 14th of December 2022. Based on the key measurements obtained from Clinica Baviera's financial statements, Clinica Baviera is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Clinica Baviera Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Clinica Baviera has an asset utilization ratio of 129.09 percent. This indicates that the Company is making €1.29 for each dollar of assets. An increasing asset utilization means that Clinica Baviera is more efficient with each dollar of assets it utilizes for everyday operations.Clinica Baviera Ownership Allocation
Clinica Baviera holds a total of 16.3 Million outstanding shares. Clinica Baviera shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 91.61 percent of Clinica Baviera outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Clinica Baviera Profitability Analysis
The company reported the revenue of 172.73 M. Net Income was 27.39 M with profit before overhead, payroll, taxes, and interest of 89.2 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Clinica Baviera's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Clinica Baviera and how it compares across the competition.
About Clinica Baviera Valuation
The stock valuation mechanism determines Clinica Baviera's current worth on a weekly basis. Our valuation model uses a comparative analysis of Clinica Baviera. We calculate exposure to Clinica Baviera's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Clinica Baviera's related companies.Clnica Baviera, S.A. operates a network of ophthalmological clinics. It operates approximately 80 ophthalmological clinics in Spain, Germany, Austria, and Italy. CLINICA BAVIERA is traded on Madrid SE C.A.T.S. in Spain.
8 Steps to conduct Clinica Baviera's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Clinica Baviera's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Clinica Baviera's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Clinica Baviera's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Clinica Baviera's revenue streams: Identify Clinica Baviera's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Clinica Baviera's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Clinica Baviera's growth potential: Evaluate Clinica Baviera's management, business model, and growth potential.
- Determine Clinica Baviera's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Clinica Baviera's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Clinica Stock analysis
When running Clinica Baviera's price analysis, check to measure Clinica Baviera's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clinica Baviera is operating at the current time. Most of Clinica Baviera's value examination focuses on studying past and present price action to predict the probability of Clinica Baviera's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clinica Baviera's price. Additionally, you may evaluate how the addition of Clinica Baviera to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |